LGND relationship map
LGND
Ligand Pharmaceuticals Inc
LGND sells to Industrials & materials · 11
AgenusAGEN
2°Zydus LifeSciencesunlisted
2°Zydusunlisted
LeonaBioLONA2°Sermonix Pharmaceuticalsunlisted
2°Shanghai Henlius Biotechunlisted
2°AnswerALS consortiumunlisted
Orchestra BioMedOBIOOvid TherapeuticsOVID2°Northwestern Universityunlisted
2°Marinus Pharmaceuticalsunlisted
2°Healxunlisted
Pelthos TherapeuticsPTHS2°Undisclosed wholesaler customer (35% of gross revenue)unnamed in filing
2°Undisclosed wholesaler customer (35% of 2025 gross revenue)unnamed in filing
2°Undisclosed wholesaler customer (28% of 2025 gross revenue)unnamed in filing
Hovioneunlisted—
← Buys from
LGNDLigand Pharmaceuticals Inc
Industrials & materials11 · open
SNYSanofi—Alvogenunlisted
—Arecorunlisted
—Baxterunlisted
—BeOne Medicinesunlisted
—CSL Viforunlisted
—Onounlisted
—Palvellaunlisted
—Recordatiunlisted
—Serum Institute of Indiaunlisted
—Vikingunlisted
Healthcare14 ›Sells to →
2°Zydus LifeSciencesunlisted
2°Zydusunlisted
2°Sermonix Pharmaceuticalsunlisted
2°Shanghai Henlius Biotechunlisted
2°AnswerALS consortiumunlisted
2°Northwestern Universityunlisted
2°Marinus Pharmaceuticalsunlisted
2°Healxunlisted
2°Undisclosed wholesaler customer (35% of gross revenue)unnamed in filing
2°Undisclosed wholesaler customer (35% of 2025 gross revenue)unnamed in filing
2°Undisclosed wholesaler customer (28% of 2025 gross revenue)unnamed in filing
Hovioneunlisted—
← Buys from
LGNDLigand Pharmaceuticals Inc
suppliercustomerunlisted2°second-degree (Extended)
sector groupThick line = filed share ·Moves · 12:17 ETSources